Suárez-García, I.
Gutierrez, Félix
Pérez-Molina, José A.
Moreno, Santiago
Aldamiz, Teresa
Valencia Ortega, Eulalia
Curran, Adrián
Gutiérrez González, Sara
Asensi, Víctor
Amador Prous, Concha
Jarrin, Inma
Rava, Marta http://orcid.org/0000-0003-2260-9370
,
Funding for this research was provided by:
Gilead Scholarship Program for Biomedical Research (GLD19_00106)
ISCIII- Miguel Servet (CP19CIII - 00002 contract)
Instituto de Salud Carlos III
Article History
Received: 25 July 2023
Accepted: 30 October 2023
First Online: 26 November 2023
Declarations
:
: MR received funds from Gilead Science; IS-G and AC have received conference grants or speaker fees from ViiV Healthcare, Merck Sharp & Dohme, Janssen and Gilead. EVO has received conference grants or counselling fees from Janssen, MSD, Gilead y ViiV. All other authors declare no conflict of interest.
: The CoRIS cohort was approved by the Clinical Research Ethics Committee of the Gregorio Marañón General University Hospital. This study was approved by the Carlos III Institute Research Ethics Committee (PI 05_2019) and was performed in accordance with the Declaration of Helsinki.
: All patients agree to participate in CoRIS by signing an informed consent form.